Aspirin and Dipyridamole
- Product NDC
- 0093-3064
- 11-digit product format
- 000933064
- Labeler code
- 0093
- Product ID
- 0093-3064_c1e67e51-3ce8-431b-93c4-3a2fd50c1d20
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Aspirin and Dipyridamole
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Application
- ANDA078804
- Marketing category
- ANDA
- Marketing start
- 2019-06-10
- Marketing end
- 2021-10-31
- Substance
- ASPIRIN; DIPYRIDAMOLE
- Active strength
- 25 mg/1; mg/1
- Pharmacologic classes
- Platelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE],Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC],Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0093-3064-06 | 00093306406 | 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0093-3064-06) | 2019-06-10 | 2021-10-31 | No | No | Current |